CEO has stated that the $20m revenue guidance was very conservative. They were turning customers away last year due to supply not keeping up with demand, production capacity increase was mentioned as going from $1.5m to $3m in gummies and flowers, far from peaking I would say. Moving towards 40% profit margin means we will see solid improvement in cash position also.
- Forums
- ASX - By Stock
- Ann: Revenue Guidance
BXN
bioxyne limited
Add to My Watchlist
2.04%
!
4.8¢

CEO has stated that the $20m revenue guidance was very...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.8¢ |
Change
-0.001(2.04%) |
Mkt cap ! $103.9M |
Open | High | Low | Value | Volume |
4.8¢ | 4.9¢ | 4.8¢ | $144.3K | 2.982M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 170644 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 260000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 170644 | 0.048 |
3 | 490120 | 0.047 |
5 | 1755239 | 0.046 |
3 | 542200 | 0.045 |
2 | 125000 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 260000 | 2 |
0.050 | 690000 | 3 |
0.051 | 431323 | 3 |
0.052 | 1323000 | 4 |
0.053 | 1412577 | 7 |
Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
Featured News
BXN (ASX) Chart |